| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 11/24/2005 | US20050260201 Methods of treating rheumatoid arthritis using anti-TNF receptor fusion proteins |
| 11/24/2005 | US20050260200 Antigenic peptides reacting with anti-ovary antibodies |
| 11/24/2005 | US20050260199 For inhibition of viral entry into cells; purified antibodies |
| 11/24/2005 | US20050260198 Inhibition of factor B, the alternative complement pathway and methods related thereto |
| 11/24/2005 | US20050260197 Receptor for Oncostatin M |
| 11/24/2005 | US20050260196 Method of treating cancer and identifying novel anti-cancer compounds |
| 11/24/2005 | US20050260195 Treatment of hepatitis B virus infection with human monoclonal antibodies |
| 11/24/2005 | US20050260194 Immunoglobulin chimeric monomer-dimer hybrids |
| 11/24/2005 | US20050260193 Steroid sparing agents and methods of using same |
| 11/24/2005 | US20050260192 Leukocyte function associated antigens comprising integrin I-domain for use in identifying modulators for prevention and treatment of inflammatory disorders; immunosuppressive agents |
| 11/24/2005 | US20050260191 for determining bioactive intact PTH levels in serum, plasma, and/or cell culture media; have a novel recognition for amino acid residues extending beyond the first N-terminal PTH residue; have binding affinity and specificity for PTH that have mitigated cross-reactivity to large non (1-84) PTH fragments |
| 11/24/2005 | US20050260190 Therapeutic agent for iNOS generating illness |
| 11/24/2005 | US20050260189 Microbubble compositions, and methods for preparing and using same |
| 11/24/2005 | US20050260168 Compositions comprising viruses and methods for concentrating virus preparations |
| 11/24/2005 | US20050260156 Modified vaccinia virus ankara for the vaccination of neonates |
| 11/24/2005 | US20050260132 Monoclonal antibodies directed to receptor protein tyrosine phosphatase zeta |
| 11/24/2005 | US20050259281 Method, apparatus and computer program for transforming digital colour images |
| 11/24/2005 | CA2820168A1 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 11/24/2005 | CA2816163A1 Methods and kits to detect hereditary angioedema type iii |
| 11/24/2005 | CA2812040A1 Antibodies |
| 11/24/2005 | CA2567301A1 Therapeutic, prophylactic and diagnostic agents for hepatitis b |
| 11/24/2005 | CA2566759A1 Method and formulation for transdermal delivery of immunologically active agents |
| 11/24/2005 | CA2566721A1 Phospholipase c gamma modulation and uses thereof for management of pain and nociception |
| 11/24/2005 | CA2566716A1 Prolongation of survival of an allograft by inhibiting complement activity |
| 11/24/2005 | CA2566632A1 Polypeptides from non-typeable haemophilus influenzae |
| 11/24/2005 | CA2566588A1 Methods for reducing biofilm formation in infectious bacteria |
| 11/24/2005 | CA2566305A1 Antibodies |
| 11/24/2005 | CA2565874A1 Humanized fc.gamma.riib specific antibodies and methods of use thereof |
| 11/24/2005 | CA2565859A1 Pulmonary malarial vaccine |
| 11/24/2005 | CA2565424A1 Macromolecule-containing sustained release intraocular implants and related methods |
| 11/24/2005 | CA2565247A1 Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates |
| 11/24/2005 | CA2565070A1 Anti-ctgf agents for the treatment of pancreatic cancer |
| 11/24/2005 | CA2565063A1 Glycoprotein vi antibodies and method thereof |
| 11/24/2005 | CA2564934A1 Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine |
| 11/24/2005 | CA2564126A1 Method of inducing immunity against stratum corneum chymotrytic enzyme |
| 11/24/2005 | CA2563796A1 Diagnostic assay for trypanosoma cruzi infection |
| 11/24/2005 | CA2563671A1 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 11/24/2005 | CA2563396A1 Method of using adenoviral vectors to induce an immune response |
| 11/24/2005 | CA2563305A1 Combination therapies for cancer and proliferative angiopathies |
| 11/24/2005 | CA2562283A1 Methods, compositions, and preparations for delivery of immune response modifiers |
| 11/24/2005 | CA2562024A1 Methods for treating bone cancer pain by administering a nerve growth factor antagonist |
| 11/24/2005 | CA2561719A1 Vaccine comprising an attenuated pestivirus |
| 11/24/2005 | CA2560103A1 Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor (tfpi) |
| 11/23/2005 | EP1598671A1 Diagnosis and therapy of cancer using SGP28-related molecules |
| 11/23/2005 | EP1598425A1 Modified Vaccinia Ankara virus variant |
| 11/23/2005 | EP1598369A1 Antibody and use thereof |
| 11/23/2005 | EP1598368A1 Anti-pci neutralizing antibody |
| 11/23/2005 | EP1598362A2 Chlamidya trachomatis antigens |
| 11/23/2005 | EP1598074A1 Stabilized preparation containing protein |
| 11/23/2005 | EP1598054A2 Method of suppressing appetite |
| 11/23/2005 | EP1597589A2 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine 1f receptor (5-ht1f) |
| 11/23/2005 | EP1597400A1 Methods of producing influenza vaccine compositions |
| 11/23/2005 | EP1597390A2 Loading of cells with antigens by electroporation |
| 11/23/2005 | EP1597385A1 DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7A1 (PDE7a1) |
| 11/23/2005 | EP1597378A2 Production of multimeric proteins |
| 11/23/2005 | EP1597376A2 Chicken rna polymerisate i promoter and the use thereof |
| 11/23/2005 | EP1597370A1 Rhesus carcino embryonic antigen, nucleotides encoding same, and uses thereof |
| 11/23/2005 | EP1597359A1 Inactivated nodavirus vaccine |
| 11/23/2005 | EP1597356A2 Cultured cd14+ antigen presenting cells |
| 11/23/2005 | EP1597350A2 Nucleic acid molecules, polypeptides, antibodies and compositions containing same useful for treating and detecting influenza virus infection |
| 11/23/2005 | EP1597348A2 Conserved and specific streptococcal genomes |
| 11/23/2005 | EP1597281A1 Method for reducing levels of c-reactive protein |
| 11/23/2005 | EP1597280A2 Monoclonal antibody production by ebv transformation of b cells |
| 11/23/2005 | EP1597275A2 Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof |
| 11/23/2005 | EP1597274A2 Hsp60 from arthrobacter |
| 11/23/2005 | EP1596885A2 Uses of anti-insulin-like growth factor i receptor antibodies |
| 11/23/2005 | EP1596883A1 Interferon drug therapy for the treatment of viral diseases and liver fibrosis |
| 11/23/2005 | EP1596882A2 Immunogenic acute phase protein-antigenic molecule complexes and fusion proteins |
| 11/23/2005 | EP1596880A2 Methods and compositions for suppressing fibrocyte differentiation |
| 11/23/2005 | EP1596871A2 T cell regulation |
| 11/23/2005 | EP1596834A2 Microparticles comprising polynucleotides adsorbed on the surface of or entrapped within the microparticles |
| 11/23/2005 | EP1596811A2 Compositions and methods to modulate immune and inflammatory responses |
| 11/23/2005 | EP1596809A2 Abeta binding molecules |
| 11/23/2005 | EP1596807A2 Immune regulation based on the targeting of early activation molecules |
| 11/23/2005 | EP1596806A2 Compositions and methods for treating cancer using igsf9 and liv-1 |
| 11/23/2005 | EP1596804A2 SOLUBLE FcyR FUSION PROTEINS AND METHODS OF USE THEREOF |
| 11/23/2005 | EP1596799A2 Therapy via targeted delivery of nanoscale particles |
| 11/23/2005 | EP1383872B1 Genetically modified yt cell line and use thereof |
| 11/23/2005 | EP1381628B1 Inflammation-specific peptides and the uses thereof |
| 11/23/2005 | EP1287026B1 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
| 11/23/2005 | EP1226264B1 Cell lines and constructs useful in production of e1-deleted adenoviruses in absence of replication competent adenovirus |
| 11/23/2005 | EP1078007B1 Verotoxin b subunit for immunization |
| 11/23/2005 | EP1039930B1 ADJUVANTED VACCINE COMPRISING AN ANTIGEN FROM STREPTOCOCCUS PNEUMONIAE AND A CpG OLIGONUCLEOTIDE |
| 11/23/2005 | EP0837939B1 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods |
| 11/23/2005 | EP0792347B1 Methods for producing enhanced antigenic helicobacter sp. and vaccines comprising same |
| 11/23/2005 | EP0781344B1 Novel implant and novel vector for the treatment of acquired diseases |
| 11/23/2005 | EP0778780B1 Capsular polysaccharide immunomodulator |
| 11/23/2005 | CN1701121A Improved transfection of eukaryontic cells with linear polynucleotides by electroporation |
| 11/23/2005 | CN1701079A Genes and polypeptides relating to chronic myeloid leukemia |
| 11/23/2005 | CN1700929A Vaccines containing viruses involved in avian malabsorption syndrome and methods of administration therefor |
| 11/23/2005 | CN1698894A Tumor necrosis factor antagonists and their use in endometriosis |
| 11/23/2005 | CN1698893A Application of hog cholera vaccine and aftosa vaccine in treating human virus infectious chronic contagious disease |
| 11/23/2005 | CN1698892A Inactivated vaccine of cow chlamydia, its preparation and inspection method |
| 11/23/2005 | CN1228450C Antigenic preparations |
| 11/23/2005 | CN1228088C Cross-breed vaccine carrier and its application |
| 11/23/2005 | CN1228086C Preparation process for combined vaccine |
| 11/23/2005 | CN1228085C Forest cerebritis purifying vaccine |
| 11/23/2005 | CN1228084C Method of using Zot or zonulin to inhibit lymphocyte proliferation in antigen-specific manner |
| 11/22/2005 | US6967240 proteinaceous compound or functionally active derivative thereof having a binding site for a group of toxins derived from various cyanobacteria, to a method for its production, diagnostic kits, and affinty matrix for use in immunoaffinity column |
| 11/22/2005 | US6967108 use of human monoclonal antibodies in a method for detecting antibodies to IA-2, a method for detecting antibodies to the islet cell antigen IA-2 and a method for detecting the islet cell antigen IA-2 in a sample |